Literature DB >> 2478222

Interleukin-6 and interleukin-1 production in acute leukemia with monocytoid differentiation.

C E van der Schoot1, P Jansen, M Poorter, M R Wester, A E von dem Borne, L A Aarden, R H van Oers.   

Abstract

Several authors have reported the in vitro production of colony-stimulating factors (CSF) and interleukin-1 (IL-1) by the neoplastic cells from patients with acute myeloid leukemia (AML). Using a sensitive bioassay for IL-6, the capacity of the leukemic cells of 30 patients with AML to produce IL-6 was examined. IL-6 production was found to be specific for cells from patients with an AML with monocytic differentiation (12 of 15 M4 and M5 patients, 0 of 15 M1 and M2 patients). Moreover, IL-6 production was paralleled by IL-1 production. The IL-6- and IL-1-producing cells were mainly found in the more mature monocytic cell fractions, defined as CD14-positive and CD34-negative adherent cells. By limiting dilution experiments, it could be excluded that the production of IL-1 or IL-6 was due to contamination with normal monocytes.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2478222

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  11 in total

1.  Effects of Allergina on the treatment of otitis media with effusions.

Authors:  Hyun-Ja Jeong; Seung-Heon Hong; Sung-Chul Kim; Eun-Jeong Park; Chul-Ho Jang; Kyung-Suk Kim; Hyung-Min Kim
Journal:  Inflammation       Date:  2002-04       Impact factor: 4.092

2.  High interleukin-6 plasma levels in acute promyelocytic leukemia.

Authors:  R Stasi; A Venditti; G del Poeta; M Tribalto; U Coppetelli; G Zaccari; G Papa
Journal:  Ann Hematol       Date:  1992-06       Impact factor: 3.673

3.  Clinical significance of plasmacytosis in the day+14 bone marrow of patients with acute myeloid leukaemia undergoing induction chemotherapy.

Authors:  Nada Al-Shughair; Ghuzayel Al-Dawsari; Martin Gyger; Gamal Mohamed; George Roberts
Journal:  J Clin Pathol       Date:  2006-05-26       Impact factor: 3.411

4.  Growth modulation of low density lipoprotein receptor sterol sensitivity in cultured human fibroblasts.

Authors:  L Tatidis; S Vitols
Journal:  Lipids       Date:  2001-11       Impact factor: 1.880

5.  Interleukin-6 does not support interleukin-2 induced generation of human lymphokine-activated killer cells.

Authors:  H G Klingemann; E Wong
Journal:  Cancer Immunol Immunother       Date:  1991       Impact factor: 6.968

6.  Effects of an anti-interleukin-6 (IL-6) murine monoclonal antibody in a patient with acute monoblastic leukemia.

Authors:  R Bataille; X G Zhang; J Wijdenes; J F Schved; B Klein
Journal:  Med Oncol Tumor Pharmacother       Date:  1993

Review 7.  Interleukin-6 in clinical medicine.

Authors:  J Bauer; F Herrmann
Journal:  Ann Hematol       Date:  1991-06       Impact factor: 3.673

8.  Acute Myelogenous Leukemia Cells Secrete Factors that Stimulate Cellular LDL Uptake via Autocrine and Paracrine Mechanisms.

Authors:  Hasanuzzaman Bhuiyan; Michèle Masquelier; Loukas Tatidis; Astrid Gruber; Christer Paul; Sigurd Vitols
Journal:  Lipids       Date:  2017-05-09       Impact factor: 1.880

9.  Interactions between rnacrophage cytokines and eicosanoids in expression of antitumour activity.

Authors:  S Ben-Efraim
Journal:  Mediators Inflamm       Date:  1992       Impact factor: 4.711

10.  Cancer immunotherapy: potential involvement of mediators.

Authors:  S Ben-Efraim
Journal:  Mediators Inflamm       Date:  1997       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.